Drawing from personal experience, Patty Keating advocates for greater awareness, improved diagnosis, and treatment among ...

Parathyroid diseases are disorders of parathyroid gland function, resulting in abnormally high (primary hyperparathyroidism) or low (primary hypoparathyroidism) levels of calcium and parathyroid ...

Dear Annie: I just read your column about the woman whose sister-in-law has become exceedingly short-tempered and abusive, ...

5,6 It is an endocrine disorder in which the production of parathyroid hormone (PTH) by the parathyroid glands is abnormally low or absent, causing low levels of calcium (hypocalcaemia ...

It happens when your body doesn’t make enough parathyroid hormone (PTH) or has undetected amounts of PTH. As a result, you have low levels of calcium in your blood, too much phosphorus in your ...

The Hospital for Endocrine Surgery, the world's leading destination for thyroid, parathyroid, and adrenal surgery, proudly ...

Septerna Inc. has announced its decision to discontinue a healthy volunteer phase I trial of SEP-786, an oral small-molecule agonist of the parathyroid hormone 1 receptor being developed for the ...

Septerna (SEPN) announced its decision to discontinue the Phase 1 single- and multiple-ascending dose clinical trial of SEP-786 in healthy ...

YORVIPATH is a first-in-class PTH replacement therapy. A prodrug of parathyroid hormone (PTH [1-34]), YORVIPATH is administered subcutaneously once daily, with sustained release of active PTH ...

YORVIPATH is a first-in-class PTH replacement therapy. A prodrug of parathyroid hormone (PTH [1-34]), YORVIPATH is administered subcutaneously once daily, with sustained release of active PTH designed ...